The emerging treatment of the medication represents a exciting advance in the care of type 2 diabetes. Different to existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide311080.csublogs.com/49958169/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment